Prefilled Syringes Market Size to Reach US$ 15.00 Billion
US & Canada, March 28, 2025 (GLOBE NEWSWIRE) -- US & Canada, Mar, 21, 2025 (GlobeNewswire) -- According to a comprehensive report from The Insight Partners, “ Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report”, The prefilled syringe market size is projected to reach US$ 15,00 Billion by 2030 from US$ 6.69 Billion in 2022; the market is estimated to record a CAGR of 10.6% from 2022 to 2030.
The global prefilled syringes market is growing significantly with an increasing prevalence of chronic diseases.
The prefilled syringes market is segmented on the basis of type, material, design, application, and distribution channel. The report runs an in-depth analysis of market trends, key players, and future
1. The global prefilled syringe market is expected to reach US$ 15.0 Billion in 2030 from US$ 6.69 Billion in 2022. The market is estimated to register a 10.6% CAGR during 2022–2030. The increasing prevalence of chronic disorders and the growing adoption of self-injecting parenteral devices drive the market growth. However, increasing product recalls hampers the prefilled syringe market growth.
2. : Increased prevalence of chronic diseases fuels the demand for biologic drugs, thereby propelling the prefilled syringe market. Most of the chronic diseases such as cancer, diabetes, rheumatoid arthritis, and autoimmune disorders involve long-term treatment schedules with injectable drugs. The diseases are increasing all over the world owing to an aging population, unhealthy lifestyles, and genetic predispositions. Thus, biologic drugs that often necessitate injection have proved to be irreplaceable in the management of these illnesses, and prefilled syringes offer an ideal and desirable presentation of drug administration.
Insulin is typically administered by subcutaneous injection, and prefilled syringes are increasingly available to make it more convenient and accurate. According to the WHO, the proportion of adults over 18 years old with diabetes was 9.3% in 2019 and is estimated to grow to 10.9% by 2045. In 2022, an estimated 537 million adults had diabetes, and this is estimated to grow significantly. Biologic drugs, including tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, and monoclonal antibodies, are used in the management of RA. They are typically administered in subcutaneous form through injections that are commonly performed with prefilled syringes. As per the CDC, in 2022, the age-adjusted prevalence of diagnosed arthritis among adults 18 years and older was 18.9%, which was higher among women (21.5%) than men (16.1%).
3. : The increasing trend toward self-injectable drugs boosts the market growth. The patients are increasingly self-managing their diseases at home, thus driving the demand for convenient drug delivery systems, including prefilled syringes. This trend is most prominent in the management of chronic conditions such as diabetes and rheumatoid arthritis, where repeated injectable treatment is needed. Patients prefer self-injecting their injectable drugs as it is convenient, independent, and flexible. The COVID-19 pandemic also fueled the trend toward home healthcare, as most patients wanted to bypass going to hospitals. Easy-to-use prefilled syringes have also emerged as the drug of choice for self-injection. Home-based healthcare is a vital part of caring for long-term conditions. The Home Care Association of America (HCAOA) 2021 Survey on Home Healthcare Trends found that 80% of healthcare executives feel the future of healthcare is moving toward home care, creating demand for products that enable patients to self-administer their treatments. Prefilled syringes are a key part of this shift, providing a safe, effective, and easy-to-use solution for injectable therapies in the home setting.
4. : In 2022, North America led the market with a substantial revenue share, followed by Europe and APAC, respectively. Asia Pacific is expected to register the highest CAGR in the prefilled syringes market during the forecast period.
The prefilled syringes market is driven by the growing uptake of biologics and biosimilars, as well as the increasing need for injectable drugs to be self-administered. The market is growing at a fast rate as patients, particularly those with chronic diseases, desire more convenient, precise, and safer means of delivering their medications at home. With biologics increasingly being used to treat diseases such as cancer and autoimmune disorders and self-injection becoming more widespread, prefilled syringes are well placed to continue growing. The evolution of syringe technology underpins growth, the requirement for accuracy in biologic dosing, and the wider trend of home.
The report from The Insight Partners lists several stakeholders—including Manufacturers, Healthcare Providers, Distributors and Suppliers, and Regulatory Bodies—along with valuable insights to successfully navigate this evolving market landscape and unlock new opportunities.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Défense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
E-mail: [email protected]
Phone: +1-646-491-9876
Press Release- https://www.theinsightpartners.com/pr/prefilled-syringe-market
